Center for Health and Behavior, Syracuse University, USA.
Psychol Addict Behav. 2012 Sep;26(3):393-405. doi: 10.1037/a0027565. Epub 2012 Mar 19.
Interventions challenging alcohol expectancies may lead to reductions in alcohol consumption. We conducted a meta-analysis to examine the efficacy of alcohol expectancy challenge (EC) interventions for college alcohol abuse prevention. Included were 14 studies (19 EC interventions) that measured alcohol expectancies and consumption, provided sufficient information to calculate effect sizes, and were available as of June 2010 (N=1,415; M age=20 years; 40% women; 88% White). Independent raters coded participant characteristics, design and methodological features, and intervention content, and calculated weighted mean effect sizes at first follow-up, using both fixed and random effects models. Compared with controls, EC participants reported lower positive alcohol expectancies, reduced their alcohol use, and reduced their frequency of heavy drinking (d+s ranged from 0.23 to 0.28). Within-group improvements in alcohol expectancies and consumption emerged for the EC group only; relative to their own baseline, EC participants reported lower positive alcohol expectancies, reduced their alcohol use, and reduced their frequency of heavy drinking (d+s ranged from 0.13 to 0.36). Supplemental analyses found improvements in specific alcohol expectancies (social, sexual, tension, and arousal) both between groups and within group. The short-term effects of EC interventions on college student drinking are not maintained at follow-ups greater than 4 weeks.
干预挑战酒精期望可能会导致饮酒量减少。我们进行了一项荟萃分析,以检验酒精期望挑战(EC)干预措施预防大学生酗酒的效果。纳入的研究有 14 项(19 项 EC 干预措施),这些研究测量了酒精期望和饮酒量,提供了足以计算效应大小的信息,并于 2010 年 6 月截止(N=1415;平均年龄 20 岁;40%为女性;88%为白人)。独立评估者对参与者特征、设计和方法特征以及干预内容进行了编码,并使用固定和随机效应模型计算了首次随访时的加权平均效应大小。与对照组相比,EC 参与者报告的积极酒精期望较低,饮酒量减少,重度饮酒频率降低(d+s 范围为 0.23 至 0.28)。只有 EC 组的酒精期望和饮酒量在组内出现改善;与自身基线相比,EC 参与者报告的积极酒精期望较低,饮酒量减少,重度饮酒频率降低(d+s 范围为 0.13 至 0.36)。补充分析发现,EC 干预措施对大学生饮酒的特定酒精期望(社交、性、紧张和唤醒)产生了组间和组内的改善。EC 干预措施对大学生饮酒的短期影响在 4 周以上的随访中无法维持。